Admission to Trading
In brief · summary, not quotable
Dr. Martens plc has announced the admission of 26,197 further ordinary shares to trading on the London Stock Exchange's Main Market, bringing the total number of shares in issue to 967,969,739. These shares, fully fungible with existing ordinary shares, were admitted between June 1 and June 30, 2026, under a block admission established in December 2024, primarily in connection with the company's employee share schemes.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your DOCS notes
The following notification is made in accordance with PRM 1.6.4R.
| 1 | Details of the issuer | |
| a) | Name | Dr. Martens plc |
| b) | LEI | 213800QPT8YM6NQZPH28 |
| 2 | Details of the transferable securities admitted to trading | |
| a) | Name, type and identification code | Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 |
| b) | Regulated market | London Stock Exchange - Main Market (XLON) |
| c) | Number of further securities issued and admitted | 26,197 |
| d) | Total number of securities in issue following admission | 967,969,739 |
| e) | Fungibility | Fully fungible with existing Ordinary Shares |
| 3 | Admission details | |
| a) | Date(s) of admission | 1 June 2026 to 30 June 2026 (admitted under a block admission dated 12 December 2024 in connection with the Company's employee share schemes) |
| b) | Prospectus information | N/A |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.